137 related articles for article (PubMed ID: 15449723)
1. New aromatic esters of progesterone as antiandrogens.
Bratoeff E; Ramírez E; Flores E; Sánchez M; Heuze I; Cabeza M
J Enzyme Inhib Med Chem; 2004 Apr; 19(2):99-105. PubMed ID: 15449723
[TBL] [Abstract][Full Text] [Related]
2. New progesterone esters as 5alpha-reductase inhibitors.
Cabeza M; Heuze I; Bratoeff E; Murillo E; Ramirez E; Lira A
Chem Pharm Bull (Tokyo); 2001 Sep; 49(9):1081-4. PubMed ID: 11558590
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological evaluation of 4-halo progesterone derivatives as antiandrogen.
Cabeza M; Quiroz A; Bratoeff E; Murillo ME; Ramírez E; Flores G
Chem Pharm Bull (Tokyo); 1999 Sep; 47(9):1232-6. PubMed ID: 10517005
[TBL] [Abstract][Full Text] [Related]
4. Androgenic and anti-androgenic effects of progesterone derivatives with different halogens as substituents at the C-6 position.
Cabeza M; Gutiérrez E; Miranda R; Heuze I; Bratoeff E; Flores G; Ramírez E
Steroids; 1999 Jun; 64(6):413-21. PubMed ID: 10433178
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of new progesterone esters as 5alpha-reductase inhibitors.
Ramírez E; Cabeza M; Bratoeff E; Heuze I; Pérez V; Valdez D; Ochoa M; Teran N; Jimenez G; Ramírez T
Chem Pharm Bull (Tokyo); 2005 Dec; 53(12):1515-8. PubMed ID: 16327180
[TBL] [Abstract][Full Text] [Related]
6. Antiandrogenic effect of 16-substituted, non-substituted and D-homopregnane derivatives.
Bratoeff EA; Herrera H; Ramírez E; Solorzano K; Murillo E; Quiróz A; Cabeza M
Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1249-55. PubMed ID: 10993221
[TBL] [Abstract][Full Text] [Related]
7. Relative binding affinity of novel steroids to androgen receptors in hamster prostate.
Cabeza M; Heuze I; Sánchez M; Bratoeff E; Ramírez E; Rojas A; Orozco A; Mungía A; Agustín G; Cuatepotzo L; Gonzalez C; Palma S; Padilla D; Perez V; Jimenez G
J Enzyme Inhib Med Chem; 2005 Aug; 20(4):357-64. PubMed ID: 16206830
[TBL] [Abstract][Full Text] [Related]
8. Aromatic esters of progesterone as 5alpha-reductase and prostate growth inhibitors.
Bratoeff E; Segura T; Recillas S; Carrizales E; Palacios A; Heuze I; Cabeza M
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):655-62. PubMed ID: 18825535
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5alpha-reductase inhibitors.
Bratoeff E; Cabeza M; Pérez-Ornelas V; Recillas S; Heuze I
J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):275-81. PubMed ID: 18644453
[TBL] [Abstract][Full Text] [Related]
10. Molecular interactions of new pregnenedione derivatives.
Bratoeff E; Ramírez E; Flores E; Valencia N; Sánchez M; Heuze I; Cabeza M
Chem Pharm Bull (Tokyo); 2003 Oct; 51(10):1132-6. PubMed ID: 14519916
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of progesterone derivatives as 5alpha-reductase inhibitors, and their effect on hamster prostate weight.
Bratoeff E; Zambrano A; Heuze I; Palacios A; Ramírez D; Cabeza M
J Enzyme Inhib Med Chem; 2010 Jun; 25(3):306-11. PubMed ID: 19874206
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacological evaluation of new 16-methyl pregnane derivatives.
Ramirez E; Cabeza M; Heuze I; Gutiérrez E; Bratoeff E; Membrillo M; Lira A
Chem Pharm Bull (Tokyo); 2002 Jan; 50(1):15-20. PubMed ID: 11824579
[TBL] [Abstract][Full Text] [Related]
13. Steroidal antiandrogens and 5alpha-reductase inhibitors.
Bratoeff E; Ramírez E; Murillo E; Flores G; Cabeza M
Curr Med Chem; 1999 Dec; 6(12):1107-23. PubMed ID: 10519917
[TBL] [Abstract][Full Text] [Related]
14. Molecular interactions of progesterone derivatives with 5 alpha-reductase types 1 and 2 and androgen receptors.
Bratoeff E; García P; Heuze Y; Soriano J; Mejía A; Labastida AM; Valencia N; Cabeza M
Steroids; 2010 Jul; 75(7):499-505. PubMed ID: 20359488
[TBL] [Abstract][Full Text] [Related]
15. New 5alpha-reductase inhibitors: in vitro and in vivo effects.
Pérez-Ornelas V; Cabeza M; Bratoeff E; Heuze I; Sánchez M; Ramírez E; Naranjo-Rodríguez E
Steroids; 2005 Mar; 70(3):217-24. PubMed ID: 15763601
[TBL] [Abstract][Full Text] [Related]
16. 5 Alpha-reductase inhibitory and antiandrogenic activities of novel steroids in hamster seminal vesicles.
Cabeza M; Bratoeff E; Flores E; Ramírez E; Calleros J; Montes D; Quiroz A; Heuze I
Chem Pharm Bull (Tokyo); 2002 Nov; 50(11):1447-52. PubMed ID: 12419908
[TBL] [Abstract][Full Text] [Related]
17. New progesterone derivatives as inhibitors of 5alpha-reductase enzyme and prostate cancer cell growth.
Cabeza M; Bratoeff E; Heuze I; Rojas A; Terán N; Ochoa M; Ramírez-Apan T; Ramírez E; Pérez V; Gracia I
J Enzyme Inhib Med Chem; 2006 Aug; 21(4):371-8. PubMed ID: 17059168
[TBL] [Abstract][Full Text] [Related]
18. Novel 17 substituted pregnadiene derivatives as 5 alpha-reductase inhibitors and their binding affinity for the androgen receptor.
Cabeza M; Flores E; Heuze I; Sánchez M; Bratoeff E; Ramírez E; Francolugo VA
Chem Pharm Bull (Tokyo); 2004 May; 52(5):535-9. PubMed ID: 15133203
[TBL] [Abstract][Full Text] [Related]
19. Novel C-6 substituted and unsubstituted pregnane derivatives as 5alpha-reductase inhibitors and their effect on hamster flank organs diameter size.
Cabeza M; Zambrano A; Heuze I; Carrizales E; Palacios A; Segura T; Valencia N; Bratoeff E
Steroids; 2009 Oct; 74(10-11):793-802. PubMed ID: 19406144
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of new pregnane derivatives as 5alpha-reductase inhibitor.
Cabeza M; Heuze I; Bratoeff E; Ramírez E; Martínez R
Chem Pharm Bull (Tokyo); 2001 May; 49(5):525-30. PubMed ID: 11383600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
